Qian‐sheng Yu

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

Nigel H. Greig, Tada Utsuki, Qian‐sheng Yu et al. · Current Medical Research and Opinion · 2001 · 411 citations

Medicine, Neuroscience, Pharmacology +14

A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide

Carsten Culmsee, Xiaoxiang Zhu, Qian‐sheng Yu et al. · Journal of Neurochemistry · 2001 · 316 citations

Life Sciences, Neuroscience, Pharmacology +17

Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease

Qian‐sheng Yu, Harold W. Holloway, Tadanobu Utsuki et al. · Journal of Medicinal Chemistry · 1999 · 210 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development

Karen T. Y. Shaw, Tadanobu Utsuki, Jack T. Rogers et al. · Proceedings of the National Academy of Sciences · 2001 · 208 citations · Full text

Medicine, Neuroscience, Pharmacology +17

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism

Wenzhen Duan, Xiaoxiang Zhu, Bruce Ladenheim et al. · Annals of Neurology · 2002 · 204 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17